Literature DB >> 3094628

Plasminogen activators in human colorectal neoplasia.

J S Gelister, M Mahmoud, M R Lewin, P J Gaffney, P B Boulos.   

Abstract

A crucial step in the transition from adenomatous polyp to invasive colorectal cancer is the degradation of the epithelial basement membrane. Plasminogen activators may play a part in regulating the extracellular protease environment necessary for this to occur. Both functional and antigenic activity of the two principal activators of plasminogen, tissue plasminogen activator and urokinase, were measured in 30 colorectal cancers, matched samples of mucosa, and eight adenomatous polyps. Both polyps (p less than 0.01) and carcinomas (p less than 0.001) had raised urokinase activities compared with normal mucosa, the activity being highest in the carcinomas. Activity of tissue plasminogen activator, however, was diminished in both polyps (p less than 0.01) and carcinomas (p less than 0.001) compared with normal mucosa, the values being lowest in carcinomas. Plasmin generation by urokinase--in contrast with tissue plasminogen activator--is fibrin independent and thus less subject to physiological control.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3094628      PMCID: PMC1341448          DOI: 10.1136/bmj.293.6549.728

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  18 in total

1.  Fibrinolytic activity of human tumors as measured by the fibrin-plate method.

Authors:  E E CLIFFTON; C E GROSSI
Journal:  Cancer       Date:  1955 Nov-Dec       Impact factor: 6.860

2.  Fibrinolysis in human malignant tumours.

Authors:  H I Peterson; I Kjartansson; K Korsan-Bengtsen; C M Rudenstam; L Zettergren
Journal:  Acta Chir Scand       Date:  1973

3.  Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.

Authors:  L A Liotta; R H Goldfarb; R Brundage; G P Siegal; V Terranova; S Garbisa
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

4.  A model for human colon carcinoma evolution based on the differential response of cultured preneoplastic, premalignant, and malignant cells to 12-O-tetradecanoylphorbol-13-acetate.

Authors:  E Friedman; C Urmacher; S Winawer
Journal:  Cancer Res       Date:  1984-04       Impact factor: 12.701

5.  The fibrinolytic system. A key to tumor metastasis?

Authors:  J M Malone; S L Wangensteen; W S Moore; K Keown
Journal:  Ann Surg       Date:  1979-09       Impact factor: 12.969

6.  Quantitation of tissue-type plasminogen activator in human endothelial cell cultures by use of an enzyme immunoassay.

Authors:  D C Rijken; V W van Hinsbergh; E H Sens
Journal:  Thromb Res       Date:  1984-01-15       Impact factor: 3.944

7.  Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activator.

Authors:  R L O'Grady; L I Upfold; R W Stephens
Journal:  Int J Cancer       Date:  1981-10-15       Impact factor: 7.396

8.  Plasminogen activator content of human colon tumors and normal mucosae: separation of enzymes and partial purification.

Authors:  J G Corasanti; C Celik; S M Camiolo; A Mittelman; J L Evers; A Barbasch; G H Hobika; G Markus
Journal:  J Natl Cancer Inst       Date:  1980-08       Impact factor: 13.506

9.  Procoagulant and fibrinolytic activities of gastric and colorectal cancer.

Authors:  M Szczepański; C Lucer; J Zawadzki; T Tołłoczko
Journal:  Int J Cancer       Date:  1982-09-15       Impact factor: 7.396

10.  Plasminogen activators of the pituitary gland: enzyme characterization and hormonal modulation.

Authors:  A Granelli-Piperno; E Reich
Journal:  J Cell Biol       Date:  1983-10       Impact factor: 10.539

View more
  7 in total

1.  Proteolysis in colorectal cancer.

Authors:  E A Garbett; M W Reed; N J Brown
Journal:  Mol Pathol       Date:  1999-06

Review 2.  Cathepsin B and other proteases in human colorectal carcinoma.

Authors:  J M Jessup
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

3.  Plasminogen activators in experimental colorectal neoplasia: a role in the adenoma-carcinoma sequence?

Authors:  J S Gelister; M R Lewin; H E Driver; F Savage; M Mahmoud; P J Gaffney; P B Boulos
Journal:  Gut       Date:  1987-07       Impact factor: 23.059

4.  In situ stromal expression of the urokinase/plasmin system correlates with epithelial dysplasia in colorectal adenomas.

Authors:  I Sordat; P Chaubert; P Protiva; L Guillou; L Mazzucchelli; E Saraga; J Benhattar; C Trân-Thang; A L Blum; G Dorta; B Sordat
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

5.  Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces.

Authors:  E de Jong; R J Porte; E A Knot; J H Verheijen; J Dees
Journal:  Gut       Date:  1989-02       Impact factor: 23.059

6.  Plasminogen activators in endoscopic biopsies as indicators of gastrointestinal cancer: comparison with resection specimens.

Authors:  P A de Bruin; H W Verspaget; G Griffioen; J H Verheijen; G Dooijewaard; C B Lamers
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

7.  Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas.

Authors:  P Protiva; I Sordat; P Chaubert; E Saraga; C Trân-Thang; B Sordat; A L Blum; G Dorta
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.